Literature DB >> 21664699

Cannabinoids improve driving ability in a Tourette's patient.

Alexander Brunnauer, Felix Maximilian Segmiller, Thomas Volkamer, Gerd Laux, Norbert Müller, Sandra Dehning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21664699     DOI： 10.1016/j.psychres.2011.05.033

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  12 in total

1.  Treatment of Gilles de la Tourette Syndrome with Cannabis-Based Medicine: Results from a Retrospective Analysis and Online Survey.

Authors:  Leonie M Milosev; Nikolas Psathakis; Natalia Szejko; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Cannabis Cannabinoid Res       Date:  2019-12-09

Review 2.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

3.  The Potential of Cannabinoid-Based Treatments in Tourette Syndrome.

Authors:  Bekir B Artukoglu; Michael H Bloch
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 4.  The therapeutic potential of cannabinoids for movement disorders.

Authors:  Benzi Kluger; Piera Triolo; Wallace Jones; Joseph Jankovic
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

Review 5.  The therapeutic potential of cannabis and cannabinoids.

Authors:  Franjo Grotenhermen; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-07-23       Impact factor: 5.594

6.  Tourette Syndrome and Driving.

Authors:  Karim Makhoul; Joseph Jankovic
Journal:  Mov Disord Clin Pract       Date:  2021-05-05

Review 7.  Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Authors:  Mariana Babayeva; Haregewein Assefa; Paramita Basu; Sanjeda Chumki; Zvi Loewy
Journal:  Parkinsons Dis       Date:  2016-12-05

8.  Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.

Authors:  Ewgeni Jakubovski; Kirsten Müller-Vahl
Journal:  Int J Mol Sci       Date:  2017-08-10       Impact factor: 5.923

9.  Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols.

Authors:  Ahmad Seif Kanaan; Ewgeni Jakubovski; Kirsten Müller-Vahl
Journal:  Brain Sci       Date:  2017-04-26

10.  Association of a Variant of CNR1 Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome.

Authors:  Natalia Szejko; Jakub Piotr Fichna; Krzysztof Safranow; Tomasz Dziuba; Cezary Żekanowski; Piotr Janik
Journal:  Front Genet       Date:  2020-03-04       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.